Acknowledgements

Project funding

Current and previous sources of funding can be found on the Ensembl website.

Ensembl receives majority funding from the Wellcome Trust (grant number WT108749/Z/15/Z) with additional funding for specific project components from the National Human Genome Research Institute (U41HG007234 and U41HG007823), the Biotechnology and Biological Sciences Research Council (BB/L024225/1 and BB/M011615/1), Open Targets, the Wellcome Trust (WT104947/Z/14/Z, WT200990/Z/16/Z, and WT201535/Z/16/Z) and the European Molecular Biology Laboratory. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement n° 634143 (MedBioinformatics). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement n° 733161 (MultipleMS). We also receive funding from the 'Save the Tasmanian Devil Program'.

Funding statement correct as of 11th July 2017.